The market indicates a low probability of lifespan-doubling breakthroughs for 30-year-olds.
Current market sentiment shows a strong belief that significant breakthroughs to double lifespan are unlikely, with a probability of only 14% for 'YES'. The Pulse AI also reflects a similar outlook, suggesting skepticism about imminent advancements in lifespan extension technologies.